Trial Details
COMPLETEDBasic Information
| Clinical ID | c4167 |
|---|---|
| Identifier | NCT00946946 |
| Trial Title | Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Azathioprine|DRUG: Mesalazine|DRUG: Azathioprine placebo|DRUG: Mesalazine placebo |
Participant Information
| Sponsor | Dr. Falk Pharma GmbH |
|---|---|
| City | Vienna |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2002-02 |
|---|---|
| Primary Completion Date | 2007-05 |
| Completion Date | 2009-07 |